(PDF) Pcn86 - Validation of the Impact of Treatment

Pcn86 - Validation of the Impact of Treatment Evolution in Non-Small Cell Lung Cancer (Nsclc) Model (Iten): A Discrete Event Patient Simulation

Value in Health - United Kingdom

doi 10.1016/j.jval.2018.09.168

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

MA18.02 the Impact of Treatment Evolution in NSCLC (iTEN) Model: Development and Validation

Journal of Thoracic Oncology

Respiratory Medicine

English

PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments

Value in Health

Occupational Health

English

P1.17-11 Pattern and Survival Impact of Neoadjuvant Treatment of Non-Small Cell Lung Cancer (NSCLC) in a Prospective Lung Resection Cohort

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.15-09 the Impact of Treatment Evolution in NSCLC (iTEN) Model: Survival and Cost of Treating Patients With Advanced NSCLC in 2017

Journal of Thoracic Oncology

Respiratory Medicine

English

Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)

Open Access Journal of Oncology and Medicine

English

Tumor Evolution in Non-Small-Cell Lung Cancer

Cancer Research

English

P3.15-12 Survival Impact of Patient Enrollment in Antineoplastic Drug Trials for Stage IV Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-129 Potential Impact of KRAS Molecular Profiling of Non-Squamous Non-Small Cell Lung Cancer (NSCLC).

Journal of Thoracic Oncology

Respiratory Medicine

English

Patient Preferences for Chemotherapy in the Treatment of Non-Small Cell Lung Cancer: A Multicenter Discrete Choice Experiment (DCE) Study in China

Patient Preference and Adherence

Social Sciences

English